Not only is ERβ action independent of systemic testosterone levels, but its mechanism of action is different to castration and the underlying cellular targets are uniquely different, being the prostatic stem/progenitor cells with regenerative potential and cells of origin of prostate cancer. The gene discussed is ESR2; the disease is Familial prostate cancer.